Literature DB >> 1276914

Retinofugal pathways in normal and albino axolotls.

R W Guillery, B V Updyke.   

Abstract

The retinofugal pathways of normal and albino axolotls have been studied by tracing the transport of radioactive materials after tritiated proline was injected into one eye. The pathways demonstrated by this method include crossed projections to the diencephalon, pretectum, and tectum, and a small component that goes to the midbrain tegmentum in the basal optic root. Ipsilaterally, radioactive label was found in all of the same cerebral regions, but in much smaller quantities. Although on the basis of earlier fiber degeneration studies most of the label could be interpreted as evidence for direct retinofugal pathways, some of the label, especially that in the ipsilateral tectum, does not correspond to a known pathway and may represent a small new component or have been produced by transneuronal transport mechanisms. The pattern of labeling was the same in the albino as in the normally pigmented axolotls. Thus, it appears that the abnormality of the chiasmatic pathway, which has been found in albinos of many different mammalian species, does not occur in axolotls.

Entities:  

Mesh:

Year:  1976        PMID: 1276914     DOI: 10.1016/0006-8993(76)90527-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Is abnormal retinal development in albinism only a mammalian problem? Normality of a hypopigmented avian retina.

Authors:  G Jeffery; A Williams
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

2.  Identification and morphometric evaluation of the synapses of optic nerve afferents in the optic tectum of the axolotl (Ambystoma mexicanum).

Authors:  C A Ingham; F H Güldner
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

3.  From retina to motoneurons: A substrate for visuomotor transformation in salamanders.

Authors:  Aurélie Flaive; Dimitri Ryczko
Journal:  J Comp Neurol       Date:  2022-06-03       Impact factor: 3.028

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.